biotech

National Awareness Campaign Surrounding Follow-On Biologics

Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics on February 12, 2008

Richmond-based Insmed, Inc has just launched a broad follow-on biologics education campaign. Part of the innovative campaign is the launch of a YouTube video on Friday to encourage an on-line conversation on the importance of passing an approval pathway for FOB.



Backgrounder about the video:
Mike, a scientist at Insmed, a Boulder, Colorado-based biotechnology company wants Washington to act now to allow access to safe, affordable follow-on biologics, or biogeneric medicines to treat diseases like cancer, MS, anemia, Lou Gehrig's disease or kidney failure.

Help Mike by telling your story about why Congress needs to act in the interest of patients, savings and competition.

While an estimated $20 billion worth of biologic drugs are expected to come off patent by 2015, no approval pathway currently exists at the Food and Drug Administration (FDA) to make follow-on biologics available to patients. Without this important pathway biotech companies will continue to have a monopoly and competition will not exist in the market. Without competition access to these critical medicines will remain expensive and will continue to drive up the overall healthcare expenditures in the US.




Permalink: National Awareness Campaign Surrounding Follow-On Biologics

Tags: biologics  awareness+campaign  drugs  drug+discovery  insmed  campaign  follow+biologics  national+awarenes 

Vote for National Awareness Campaign Surrounding Follow-On Biologics:

  • Currently 6.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.00 out of 3 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells